Literature DB >> 8921453

Use of psychotropic drugs and risk of myocardial infarction: a case-control study in Finnish farmers.

J Penttinen1, P Valonen.   

Abstract

BACKGROUND: In 1992 Thorogood et al. reported an increased risk of myocardial infarction in women using psychotropic drugs. The aim of our study is to find out whether there is a link between the use of psychotropic drugs and subsequent myocardial infarction in males.
METHOD: A cohort of 3172 male farmers was followed from 1 February 1980 to 31 December 1992. Those subjects who had myocardial infarction without any previous symptoms during the follow-up were considered as cases. For every case three matched controls were selected. The matched variables were age, smoking habits, social status and county. The final sample includes 83 cases and 249 controls.
RESULTS: Those who had used psychotropic drugs had increased risk for myocardial infarction, odds ratio (OR) = 2.5, 95% confidence interval (CI):1.2-5.2. Most pronounced risk for myocardial infarction was found among users of anti-depressants, OR = 5.4 (CI:1.8-16.1).
CONCLUSION: The use of psychotropic drugs, especially antidepressants, is associated with increased risk of myocardial infarction. Further attempts are needed to determine whether the relationship between use of psychotropic drugs and risk of myocardial infarction is causal or not.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921453     DOI: 10.1093/ije/25.4.760

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  11 in total

1.  Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies.

Authors:  A Biffi; L Scotti; G Corrao
Journal:  Eur J Clin Pharmacol       Date:  2017-01-09       Impact factor: 2.953

2.  Antidepressant use and risk of coronary heart disease: meta-analysis of observational studies.

Authors:  Seung-Won Oh; Joonseok Kim; Seung-Kwon Myung; Seung-Sik Hwang; Dae-Hyun Yoon
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

Review 3.  Use of antipsychotics and risk of myocardial infarction: a systematic review and meta-analysis.

Authors:  Zheng-He Yu; Hai-Yin Jiang; Li Shao; Yuan-Yue Zhou; Hai-Yan Shi; Bing Ruan
Journal:  Br J Clin Pharmacol       Date:  2016-05-23       Impact factor: 4.335

4.  Differential effects of antidepressant subgroups on risk of acute myocardial infarction: A nested case-control study.

Authors:  Rasha Alqdwah-Fattouh; Sara Rodríguez-Martín; Francisco J de Abajo; Diana González-Bermejo; Miguel Gil; Alberto García-Lledó; Francisco Bolúmar
Journal:  Br J Clin Pharmacol       Date:  2020-05-09       Impact factor: 4.335

5.  Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care.

Authors:  J Hippisley-Cox; M Pringle; V Hammersley; N Crown; A Wynn; A Meal; C Coupland
Journal:  BMJ       Date:  2001-09-22

6.  Exposure to tricyclic antidepressants is associated with an increased risk of incident CHD events in a population-based study.

Authors:  Leah B Rosenberg; William Whang; Daichi Shimbo; Ashish Shah; Peter A Shapiro; Karina W Davidson
Journal:  Int J Cardiol       Date:  2009-07-15       Impact factor: 4.164

Review 7.  The association between antipsychotic agents and the risk of myocardial infarction: a systematic review.

Authors:  Ruth Brauer; Ian Douglas; Liam Smeeth
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

Review 8.  Impact of antidepressants use on risk of myocardial infarction: A systematic review and meta-analysis.

Authors:  Krishna Undela; Gurumurthy Parthasarathi; Sharon Sunny John
Journal:  Indian J Pharmacol       Date:  2015 May-Jun       Impact factor: 1.200

9.  Antipsychotic drug use and risk of stroke and myocardial infarction: a systematic review and meta-analysis.

Authors:  Sanja Zivkovic; Chan Hee Koh; Nandita Kaza; Caroline A Jackson
Journal:  BMC Psychiatry       Date:  2019-06-20       Impact factor: 3.630

10.  Antipsychotic Medications and Risk of Acute Coronary Syndrome in Schizophrenia: A Nested Case-Control Study.

Authors:  Hsing-Cheng Liu; Shu-Yu Yang; Ya-Tang Liao; Chiao-Chicy Chen; Chian-Jue Kuo
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.